| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |